Perioperative Anesthetic, Renal Cancer
Conditions
Brief summary
The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.
Detailed description
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.
Interventions
None listed
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adult Participants (18 years of age or older) 2. Participants having radical or partial nephrectomies with curative intent.
Exclusion criteria
1. Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy 2. Biopsies 3. Participants who had radiofrequency or microwave ablations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative complications | 72 hours and 30 days postoperatively |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | Recurrence-free survival:The length of time from surgery to last seen without recurrence or with recurrent disease. | The length of time from surgery to last follow-up alive or death. |
Countries
United States
Outcome results
None listed